Phase 3 Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Placebo in Adults With Symptomatic nHCM

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2023
This clinical trial will study the effects of aficamten (versus placebo) on the quality of life, exercise capacity, and clinical outcomes of patients with non-obstructive hypertrophic cardiomyopathy.
Epistemonikos ID: bbfb10ea0da50c51f7743512eeb8d76fb67eb00b
First added on: May 15, 2024